A Systematic Review for the Development of a Core Outcome Set for Ulcerative Colitis Clinical Trials

Advances in drug development for ulcerative colitis (UC) have been paralleled by innovations in trial design. Development of a core outcome set (COS) to standardize outcome definitions and reporting in clinical trials is desirable. We aim to systematically review the efficacy and safety outcomes reported in UC placebo-controlled RCTs.

http://ift.tt/2wp4ZCH